Industry Comparables

OTC: CLCS

Stock Information

SHARE PRICE: $0.275

VOLUME: 2,855

MARKET CAP: $11,953,755.00

SHARE COUNT: 43,468,200

DAILY HIGH: $0.275

DAILY LOW: $0.26

OPEN: $0.26

CLOSE: $0.2501

PREV. CLOSE: $0.2501

CHANGE: $0.0249 (9.956026%)

52-WEEK HIGH: $0.8401

52-WEEK LOW: $0.0002

LAST UPDATED: 2 days ago

CompanySymbolMarketcapPriceExchangeChart (24H)
Cell Source, Inc.CLCS11.95M$0.275OQB
CompanySymbolMarketcapPriceExchangeChart (24H)
Allogene Therapeutics, Inc.ALLO315.03M$1.45NMS
Atara Biotherapeutics, Inc.ATRA36.15M$6.17NMS
bluebird bio, Inc.BLUE40.53M$4.14NMS
Fate Therapeutics, Inc.FATE127.20M$1.11NGM
KDMN0.0000$0.0000
Legend Biotech CorporationLEGN6.02B$32.80NMS

Investor Presentation

Investor Relations Contact

Cell Source, Inc.
57 West 57th Street, Suite 400
New York, NY 10019

Phone: 646-612-7554
Toll Free: 888-315-4650
Email: info@cell-source.com

Securities Counsel

Giordano Halleran & Ciesla
Philip D. Forlenza, Esq.
125 Half Mile Road, Suite 300
Red Bank, NJ 07701-6777

Phone: 732-741-3900
Email: PForlenza@ghclaw.com
WWW: www.ghclaw.com

Independent Auditor

Marcum LLP
750 Third Ave, 11th Floor
New York, NY 10017

Additional Information

Subscribe to Cell Source’s Newsletter

    INVESTOR ALERTS. PRESS RELEASES. INDUSTRY & COMPANY NEWS.

    Get the latest Cell Source news and updates, delivered right to your inbox.